Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit.
Song K, Guo Y, Wang X, Cai H, Zheng W, Li N, Song X, Ao L, Guo Z, Zhao W.
Song K, et al. Among authors: song x.
FASEB J. 2019 Jan;33(1):151-162. doi: 10.1096/fj.201800222RRR. Epub 2018 Jun 29.
FASEB J. 2019.
PMID: 29957060
For patients with stage II and III CRC, the coupled signatures can first identify patients with high relapse risk after curative surgery, then predict therapeutic benefit from 5-FU-based ACT.-Song, K., Guo, Y., Wang, X., Cai, H., Zheng, W., Li, N., Song, X., …
For patients with stage II and III CRC, the coupled signatures can first identify patients with high relapse risk after curative surgery, th …